Aoki, Yujiro
Satoh, Hiroyuki
Hamasaki, Yuko
Hamada, Riku
Harada, Ryoko
Hataya, Hiroshi
Ishikura, Kenji
Muramatsu, Masaki
Shishido, Seiichiro
Sakai, Ken
Article History
Received: 26 May 2021
Accepted: 23 September 2021
First Online: 27 September 2021
Declarations
:
: Yuko Hamasaki belongs to an endowed department sponsored by Asahi Kasei Pharma Corporation, Novartis Pharma K.K., Chugai Pharmaceutical Co., and Astellas Pharma (until 28/Feb/2018). Seiichiro Shishido belongs to an endowed department sponsored by Asahi Kasei Pharma Corporation, Novartis Pharma K.K., and Chugai Pharmaceutical Co. The other authors have no potential conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB approval number H29b-91) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: The requirement for informed consent was waived by the ethics committee.